Ambient

Molecular Formula : C21 D6 H20 N6 O5 S

Molecular Formula : C21 D6 H20 N6 O5 S

Molecular Formula : C23 2H5 H27 N6 O4 S

Molecular Formula : C23 2H5 H27 N6 O4 S

Molecular Formula : C13 H13 N3

Molecular Formula : C13 H13 N3

Molecular Formula : C13 H13 N3

Molecular Formula : C20H21N3O8

Molecular Formula : C19 H23 N3 O5

Molecular Formula : C19 H23 N3 O5

Molecular Formula : C13 H13 N3 . C4 H6 O6

Molecular Formula : C13 H13 N3 . C4 H6 O6

Molecular Formula : C13 H13 N3 . C4 H6 O6

Molecular Formula : C13H13D2Cl2N15N2

Molecular Formula : C13H13D2Cl2N15N2

Molecular Formula : C13H9D4N3 •xHCl

Molecular Formula : C13H9D4N3 •xHCl

Vascular Endothelial Growth Factor-165

Molecular Formula : C46H65N15O12S2 • (C2H4O2)

Molecular Formula : C46H65N15O12S2 • (C2H4O2)

Molecular Formula : C46H65N15O12S2 • (C2H4O2)

Molecular Formula : C22H8Br2O2

Molecular Formula : C22H8Br2O2

Molecular Formula : C20 H15 Cl N4 . 2 Cl H

Molecular Formula : C20 H15 Cl N4 . 2 Cl H

Molecular Formula : C20H13D4Cl3N4

Molecular Formula : C20H13D4Cl3N4

Molecular Formula : C18H16N4O3S

Molecular Formula : C18H16N4O3S

Molecular Formula : C18H16N4O3S

Molecular Formula : C34 H57 N2 O4 . Br

Molecular Formula : C34 H57 N2 O4 . Br

Molecular Formula : C34 H57 N2 O4 . Br

Molecular Formula : C19 H22 O2

Molecular Formula : C19 H22 O2

Molecular Formula : C19 H22 O2

Molecular Formula : C19H19D3O2

Molecular Formula : C19H19D3O2

Vedaprofen, NeuroPure

Veegum(R) HV, Granular

Veegum(R) HV, Granular

Veegum(R) HV, Granular

Veegum(R) R

Veegum(R) R

Veegum(R) R

Veegum(R) R

VEGETABLE OIL HYDROGENATED

Vascular Endothelial Growth Factor (VEGF) was initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and by a variety of transformed cell lines as a mitogen specific for vascular endothelial cells. It was subsequently found to be identical to an independently discovered vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based on its ability to increase the permeability of capillary blood vessels. Three mouse cDNA clones, which arise through alternative splicing and which encode mature mouse monomeric VEGF having 120, 164, or 188, amino acids, respectively, have been identified. Two receptor tyrosine kinases (RTKs), Flt-1 and Flk-1 (the mouse homologue of human KDR), both members of the type III subclass of RTKs containing seven immunoglobulin-like repeats in their extracellular domains, have been shown to bind VEGF with high affinity. The roles of the homodimers of KDR, Flt, and the heterodimer of KDR/Flt in VEGF signal transduction remain to be elucidated. In vivo, VEGF has been found to be a potent angiogenesis inducer.

Vascular Endothelial Growth Factor (VEGF) was initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and by a variety of transformed cell lines as a mitogen specific for vascular endothelial cells. It was subsequently found to be identical to an independently discovered vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based on its ability to increase the permeability of capillary blood vessels. Three mouse cDNA clones, which arise through alternative splicing and which encode mature mouse monomeric VEGF having 120, 164, or 188, amino acids, respectively, have been identified. Two receptor tyrosine kinases (RTKs), Flt-1 and Flk-1 (the mouse homologue of human KDR), both members of the type III subclass of RTKs containing seven immunoglobulin-like repeats in their extracellular domains, have been shown to bind VEGF with high affinity. The roles of the homodimers of KDR, Flt, and the heterodimer of KDR/Flt in VEGF signal transduction remain to be elucidated. In vivo, VEGF has been found to be a potent angiogenesis inducer.

Vascular Endothelial Growth Factor (VEGF) was initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and by a variety of transformed cell lines as a mitogen specific for vascular endothelial cells. It was subsequently found to be identical to an independently discovered vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based on its ability to increase the permeability of capillary blood vessels. Three mouse cDNA clones, which arise through alternative splicing and which encode mature mouse monomeric VEGF having 120, 164, or 188, amino acids, respectively, have been identified. Two receptor tyrosine kinases (RTKs), Flt-1 and Flk-1 (the mouse homologue of human KDR), both members of the type III subclass of RTKs containing seven immunoglobulin-like repeats in their extracellular domains, have been shown to bind VEGF with high affinity. The roles of the homodimers of KDR, Flt, and the heterodimer of KDR/Flt in VEGF signal transduction remain to be elucidated. In vivo, VEGF has been found to be a potent angiogenesis inducer.